Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPAID: Ibuprofen for Ectopic Bone Prevention After Hip Replacement
NCT00145730Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Feb 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in ectopic ossification (HO) comparing Ibuprofen with Placebo (2 arms). Primary endpoint: Self-reported pain and physical function. Started Feb 2002; status: completed.
02
Drugs
ibuprofen
03
Conditions
ectopic ossification (HO)
Beyond the preview
Go deeper on NCT00145730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145730.